Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY1R | P25929 | 1/20 | 0.65 |
| ▸ | NPY2R | P49146 | 1/20 | 0.65 |
| ▸ | NPY4R | P50391 | 1/20 | 0.65 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.65 |
| ▸ | CXCR4 | P61073 | 3/20 | 0.62 |
| ▸ | KISS1R | Q969F8 | 4/20 | 0.62 |
| ▸ | CXCL8 | P10145 | 9/20 | 0.62 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.59 |
| ▸ | EPHA2 | P29317 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29351200 | 0.92 | NPY2R (0.73) | NPY1RNPY2RNPY4RNPY5RCXCR4 | |
| SCHEMBL29578881 | 0.92 | NPY2R (0.73) | NPY1RNPY2RNPY4RNPY5RCXCR4 | |
| SCHEMBL30673321 | 0.91 | CXCR4 (0.60) | NPY1RNPY2RNPY4RNPY5RCXCR4 | |
| SCHEMBL31410855 | 0.89 | KISS1R (0.65) | NPY1RNPY2RNPY4RNPY5RKISS1R | |
| SCHEMBL31182571 | 0.89 | NPY2R (0.71) | NPY1RNPY2RNPY4RNPY5RCXCR4 | |
| SCHEMBL29599104 | 0.89 | NPY1R (0.65) | NPY1RNPY2RNPY4RNPY5RCXCR4 | |
| SCHEMBL31307225 | 0.89 | IL23R (0.65) | NPY1RNPY2RNPY4RNPY5RKISS1R | |
| SCHEMBL30786585 | 0.89 | KISS1R (0.68) | NPY1RNPY2RNPY4RNPY5RCXCR4 | |
| SCHEMBL29552852 | 0.89 | KISS1R (0.68) | NPY1RNPY2RNPY4RNPY5RCXCR4 | |
| SCHEMBL31000945 | 0.88 | C5AR1 (0.73) | NPY1RNPY2RNPY4RNPY5RCXCR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116082459-A | Preparation and application of targeting polypeptide H-5 specifically combined with human EGF receptor-2 | 江苏科缔思生物科技有限公司 | 2023-05-09 | — | — | CN | claimed |
| CN-116082459-A | Preparation and application of targeting polypeptide H-5 specifically combined with human EGF receptor-2 | 江苏科缔思生物科技有限公司 | 2023-05-09 | — | — | CN | disclosed |
| CN-116082459-A | Preparation and application of targeting polypeptide H-5 specifically combined with human EGF receptor-2 | 江苏科缔思生物科技有限公司 | 2023-05-09 | — | — | CN | disclosed |